Vol 3, No 2 (April 2014): Translational Gastrointestinal Cancer


Commentary: randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases
Satoshi Matsusaka
Lactate dehydrogenase acetylation adds another piece to the puzzle of metabolic reprogramming in pancreatic cancer
Rocco Sciarrillo, Filippo Minutolo, Godefridus J. Peters, Elisa Giovannetti

Original Article

Re-irradiation in recurrent rectal cancer: single institution experience
Rasha Mohammad Abdel Latif, Ghada E. El-Adawei, Wael El-Sada

Review Article

Recent advances in endoscopic management of gastrointestinal cancers
Maria Grazia Mancino, Marco Bianchi, Virginia Festa, Maurizio Koch, Angelo Dezi
Genomic instability in obesity-associated colon cancer
Jiezhong Chen, Ming-Tat Ling, Renfu Shao

Hepatocellular Carcinoma Column

The expression level of Myeloid differentiation factor 88 might be a significant biomarker for the prognosis of HCC patients
Yasuteru Kondo, Tooru Shimosegawa
Midkine as a new diagnostic tool in hepatocellular carcinoma
Jean-Charles Nault
Serum biomarkers for early diagnosis of hepatocellular carcinoma
Peipei Song, Wei Tang, Norihiro Kokudo

Case Report

An unusual pancreatic mass: a case report and literature review
Ranjita Pallavi, Pavan Mahendra Ravella, Andrea Popescu-Martinez